In patients with systemic amyloidosis, amyloid fibrils are typically deposi
ted in numerous organs, including the kidneys, heart, and liver. Although a
myloid deposition in the liver is common in patients with systemic amyloido
sis, clinical liver disease is relatively rare. The patient described here
had cholestatic liver disease as the primary manifestation of primary syste
mic amyloidosis, Review of the literature suggests that prominent liver dis
ease with cholestasis is unusual but probably underreported in patients wit
h amyloidosis and appears to be restricted to patients with the primary for
m of amyloidosis, Nonetheless, cholestatic hepatic amyloidosis is character
ized by distinct clinical, laboratory, and pathologic features; recognition
of this process is critical because it identifies patients with widespread
organ involvement and portends a poor prognosis.